A TRIAL COMPARING THE EFFICACY, PATIENT-REPORTED OUTCOMES AND SAFETY OF INSULIN DEGLUDEC 200 U/ML VS INSULIN GLARGINE IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS REQUIRING HIGH-DOSE INSULIN
Principal Investigator(s)
Cersosimo,Eugenio
Funded by
NOVO NORDISK PHARMACEUTICAL
Research Start Date
Status
Inactive